Literature DB >> 12673188

The use of prone imaging on acute resting gated myocardial perfusion imaging with Tc-99m sestamibi.

Benjamin A Lowenstein1, Roger Pezzuti, Mylan C Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673188     DOI: 10.1067/mnc.2003.400

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  4 in total

1.  Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain.

Authors:  M C Kontos; R L Jesse; K L Schmidt; J P Ornato; J L Tatum
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

2.  Quantitative comparison of prone and supine myocardial SPECT MIBI images.

Authors:  C Perault; A Loboguerrero; J C Liehn; H Wampach; C Gibold; J Ouzan; T Pron; A Fortier; A Bouchard
Journal:  Clin Nucl Med       Date:  1995-08       Impact factor: 7.794

3.  Prone versus supine thallium myocardial SPECT: a method to decrease artifactual inferior wall defects.

Authors:  G M Segall; M J Davis
Journal:  J Nucl Med       Date:  1989-04       Impact factor: 10.057

4.  Supine and prone SPECT Tc-99m MIBI myocardial perfusion imaging for dipyridamole studies.

Authors:  R Lisbona; L Dinh; V Derbekyan; J A Novales-Diaz
Journal:  Clin Nucl Med       Date:  1995-08       Impact factor: 7.794

  4 in total
  2 in total

1.  Disappearance of myocardial perfusion defects on prone SPECT imaging: comparison with cardiac magnetic resonance imaging in patients without established coronary artery disease.

Authors:  Bo Hedén; Eva Persson; Marcus Carlsson; Olle Pahlm; Håkan Arheden
Journal:  BMC Med Imaging       Date:  2009-08-10       Impact factor: 1.930

2.  Efficacy of full-fat milk and diluted lemon juice in reducing infra-cardiac activity of (99m)Tc sestamibi during myocardial perfusion imaging.

Authors:  Khushica Purbhoo; Mboyo Di Tamba Willy Vangu
Journal:  Cardiovasc J Afr       Date:  2015 Jul-Aug       Impact factor: 1.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.